Comparing the treatment outcomes between unresectable and recurrent cases receiving gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer: Pooled analysis of two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback